Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 26.46
+0.44 (1.69%)
Oct 23, 2026, 3:00 PM CST
SHA:600976 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,115 | 3,370 | 3,505 | 4,213 | 3,641 | 3,299 |
Revenue Growth | -1.90% | -3.85% | -16.81% | 15.72% | 10.35% | 34.34% |
Gross Profit Gross Profit Growth | 1,828 | 1,960 | 1,670 | 1,934 | 1,574 | 1,417 |
Operating Income Operating Income Growth | 250.34 | 224.59 | 111.6 | 313.12 | 262.77 | 207.46 |
Net Income Net Income Growth | 312.4 | 359.84 | 362.18 | 521.46 | 408.08 | 305.26 |
Earnings Per Share EPS Growth | 2.06 | 2.37 | 2.38 | 3.41 | 2.68 | 2.01 |
EPS Growth | -4.50% | -0.42% | -30.20% | 27.24% | 33.33% | 109.38% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Offset of Business Segment Offset of Business Segment Growth | -1,806 |
Commercial Commercial Growth | 1,373 |
Pharmaceutical Production and Sales Pharmaceutical Production and Sales Growth | 3,804 |
Total Total Growth | 3,370 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,403 | 1,204 | 1,117 | 999.58 | 860.71 | 840.28 |
Total Debt Total Debt Growth | 92.98 | 126.1 | 175.71 | 114.86 | 53.34 | 71.48 |
Net Cash (Debt) Net Cash Growth | 1,310 | 1,078 | 941.65 | 884.72 | 807.37 | 768.81 |
Net Cash Growth | 30.45% | 14.51% | 6.44% | 9.58% | 5.02% | 38.07% |
Net Cash Per Share Net Cash Per Share Growth | 8.63 | 7.10 | 6.19 | 5.79 | 5.30 | 5.06 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 425.69 | 274.53 | 234.27 | 268.39 | 215.87 | 247.92 |
Capital Expenditures CapEx Growth | -104.18 | -100.67 | -120.29 | -64.5 | -67.96 | -56.15 |
Free Cash Flow Free Cash Flow Growth | 321.51 | 173.86 | 113.98 | 203.89 | 147.9 | 191.77 |
Free Cash Flow Growth | 100.38% | 52.54% | -44.10% | 37.85% | -22.88% | 139.84% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.69% | 58.17% | 47.63% | 45.91% | 43.23% | 42.96% |
Operating Margin | 8.04% | 6.66% | 3.18% | 7.43% | 7.22% | 6.29% |
Pretax Margin | 11.35% | 11.60% | 11.20% | 13.56% | 12.03% | 10.35% |
Profit Margin | 10.03% | 10.68% | 10.33% | 12.38% | 11.21% | 9.25% |
FCF Margin | 10.32% | 5.16% | 3.25% | 4.84% | 4.06% | 5.81% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.900 | 0.900 | 0.900 | 1.200 | 1.000 | 0.806 |
Dividend Per Share Growth | 0% | 0% | -25.00% | 20.00% | 24.07% | 120.22% |
Dividend Yield | 3.40% | 2.68% | 2.16% | 1.86% | 2.02% | 1.02% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.85 | 14.31 | 17.65 | 19.02 | 18.50 | 39.27 |
Forward PE | - | 10.79 | 10.45 | 16.65 | 16.11 | 30.20 |
P/FCF Ratio | 12.62 | 29.62 | 56.10 | 48.63 | 51.06 | 62.52 |
PS Ratio | 1.30 | 1.53 | 1.82 | 2.35 | 2.07 | 3.63 |